Rate My Professor Michael Pollack

Pollack specializes in rehabilitation medicine with a focus on stroke rehabilitation, neurorehabilitation, spinal cord impairment, brain injury, and pain management. As Clinical Pathways Lead and a founding member of the Centre for Rehab Innovations (CRI), he has contributed over 40 peer-reviewed publications, including "Clopidogrel Administration Impairs Neurovascular Unit Recovery and Exacerbates Amyloid Beta Accumulation in Aged Mice Post-Stroke" (2026), "Biopsychosocial based machine learning models predict patient improvement after total knee arthroplasty" (2025), and "Evaluation of rural stroke services: does implementation of coordinated care improve outcomes?" (2013). His influence in the field is marked by chairing working parties for Australia's first National Guidelines on Stroke Rehabilitation and the National Framework for Stroke Rehabilitation with the National Stroke Foundation, co-founding the Australasian Stroke Unit Network (now Australasian Stroke Coalition), chairing Stroke Services NSW for the Agency for Clinical Innovation (ACI), and serving on the Executive Committee of the ACI Rehabilitation Clinical Network. Additionally, he leads the Research Working Group for the Australasian Faculty of Rehabilitation Medicine (AFRM), delivered the Burniston Oration at the 2018 RACP Congress, and is an Associate Investigator with the Centre of Research Excellence in Stroke Rehabilitation and Brain Recovery.